Dexketoprofen

DB09214ApprovedInvestigationalWithdrawnSmall molecule

Dexketoprofen is an NSAID that is the R(-)-enantiomer of racemic ketoprofen with analgesic and anti-inflammatory properties used for the treatment of mild to moderate pain. It is available in the various countries in Europe, Asia and Latin America.

Chemical structure of Dexketoprofen
Mechanism
Curator reviewed · 1 reference
Primary indication
For short-term treatment of mild to moderate pain, including dysmenorrhoea, musculoskeletal pain and toothache.Curator reviewed · 20 structured indications
Formula / weight
C16H14O3 · 254.2806 g/mol (avg)

Resolves to

Compound
UNII6KD9E78X68CAS22161-81-5ChEMBLCHEMBL75435ChEBI76128PubChem667550KEGGD07269
Clinical / RWD
RxNorm237162ATCM01AE17ATCM02AA27ATCN02AJ14PharmGKBPA166049175
Structure
InChIKeyDKYWVDODHFEZIM-NSHDSACASA-NSMILES[H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Targets
P23219PTGS1P35354PTGS2

What you can answer from here — as of September 12, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,466Drug interactionsStructured to mechanism, not free text
Sign in
76Clinical trialsPhase, status and sponsor resolved per trial
Sign in
20Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
506Marketed productsAcross 8 countries and 86 labellers
Sign in
3ATC codesIncluding every combination product, plus 26 drug categories
Sign in
24+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexketoprofen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In